ZIVO Bioscience, Inc. (ZIVO) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Bloomfield Hills, MI, United States. The current CEO is John Bernard Payne.
ZIVO has IPO date of 2003-12-15, 7 full-time employees, listed on the Other OTC, a market capitalization of $8.24M.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
